Literature DB >> 991470

Pulmonary calcification in chronic renal failure: use of diphosphonate scintiscan as a diagnostic tool.

K Devacaanthan, A U Yap, Z Chayes, R M Stein.   

Abstract

A patient with end-stage renal failure on maintenance hemodialysis for fifty-five months presented with signs and symptoms of cardiorespiratory failure and chest X-ray evidence of cardiomegaly and persistent bilateral nodular lung densities. A lung scan employing a bone seeking radionuclide, 99 Tc Diphosphonate, revealed active uptake in all areas corresponding to the X-ray densities. It was concluded that these densities represented active calcification. Thus, a diagnosis of pulmonary calcification was established without the need to resort to lung biopsy. It is suggested that bone-seeking radionuclides may be employed effectively to help establish an early diagnosis of pulmonary calcification especially in high risk dialysis patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991470

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Unusual site of extraosseous uptake of Tc 99m-HMDP due to subcutaneous heparin injections. Report of two cases.

Authors:  S Amico; P Lucas; J C Liehn; J Valeyre
Journal:  Eur J Nucl Med       Date:  1989

2.  Detection of pulmonary calcification in haemodialised patients by whole-body scintigraphy and the impact of the calcification to parameters of spirometry.

Authors:  Zvezdana Rajkovača; Peđa Kovačević; Biljana Jakovljević; Zelimir Erić
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

Review 3.  Diffuse pulmonary uptake of 99mTc bone-imaging agents: case report and survey.

Authors:  J L Coolens; P Devos; M De Roo
Journal:  Eur J Nucl Med       Date:  1985

4.  Detection and pathogenesis of visceral calcification in dialysis patients and patients with malignant disease.

Authors:  C Velentzas; H Meindok; D G Oreopoulos; H E Meema; S Rabinovich; D Sutton; R Ogilvie
Journal:  Can Med Assoc J       Date:  1978-01-07       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.